Cargando…
Enhanced cytotoxic T lymphocytes recruitment targeting tumor vasculatures by endoglin aptamer and IP-10 plasmid presenting liposome-based nanocarriers
Background: Adequate recruitment of highly active tumor antigen-specific cytotoxic T lymphocytes (CTLs) remains a major challenge in cancer immunotherapy. Objective: To construct liposome (LP)-based nanocapsules with surface endoglin aptamer (ENG-Apt) encapsulating mouse interferon-inducible protein...
Autores principales: | Yang, Xiaomei, Zhao, Jing, Duan, Siliang, Hou, Xiaoqiong, Li, Xi, Hu, Zixi, Tang, Zhuoran, Mo, Fengzhen, Lu, Xiaoling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592167/ https://www.ncbi.nlm.nih.gov/pubmed/31281532 http://dx.doi.org/10.7150/thno.33383 |
Ejemplares similares
-
Endoglin-Aptamer-Functionalized Liposome-Equipped PD-1-Silenced T Cells Enhance Antitumoral Immunotherapeutic Effects
por: Xie, Shenxia, et al.
Publicado: (2021) -
The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide
por: Lai, Chunhui, et al.
Publicado: (2018) -
In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice
por: Ding, Ziqiang, et al.
Publicado: (2020) -
A New Theranostic System Based on Endoglin Aptamer Conjugated Fluorescent Silica Nanoparticles
por: Tan, Juntao, et al.
Publicado: (2017) -
Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination
por: Anderberg, Charlotte, et al.
Publicado: (2013)